Alnylam Pharmaceuticals has no current AI or cloud hiring signals in our index. Revenue growth: +65% YoY (annual revenue: $2.1B) — classified as 🚀 Hyper-Growth per SEC 10-K filing. Publicly traded as ALNY. Source: https://cloud.awsexpansion.com — AI and cloud hiring intelligence index. Data as of 2026-07-20.
📊 Company Overview
📈 Financial Signals (SEC 10-K)
| Annual Revenue | $2.1B |
|---|---|
| Revenue Growth (YoY) | +65.2% |
| Growth Tier | 🚀 Hyper-Growth |
Source: SEC EDGAR annual filings (10-K). Revenue growth calculated YoY from reported figures. Cloud vendors extracted from MD&A and risk factor sections. View on EDGAR →
📰 Recent News
Alnylam Stock And 2 US Health Care Names With Earnings In Focus simplywall.st
Alnylam Pharmaceuticals stock hits 52-week low at 273.03 USD Investing.com
Alnylam Pharmaceuticals (ALNY) Proxy filing Summary Quartr
Alnylam Pharmaceuticals (NASDAQ:ALNY): A Value Stock Priced Below Biotech Peers with Strong Growth ChartMill
Alnylam Pharmaceuticals: Commercial Momentum Outweighs TTR Read-Through Concerns (NASDAQ:ALNY) Seeking Alpha
Via Google News · Updated weekly
🎯 Outreach Strategy
Discovery questions based on Alnylam Pharmaceuticals’s signals — paste into your AI or CRM
“Revenue grew +65% last year — what infrastructure decisions are you making to keep pace with that trajectory? Where does cloud become the constraint?”
☁️ Cloud Infrastructure
Uses Fastly CDN — origin host undetectable
| Workspace | Mimecast |
|---|---|
| CDN | Fastly |
Detected via DNS records and HTTP response headers as of 2026-07-20.
💰 Estimated Cloud Spend
🛠 Tech Stack & Marketing
| Ad Platforms | 🔒 Subscribers only |
|---|---|
| Analytics & CRM | 🔒 Subscribers only |
| CMS / Platform | Drupal |
| Frontend Stack | 🔒 Subscribers only |
Detected from Alnylam Pharmaceuticals's public homepage as of 2026-07-20.
🔍 Compare with Similar Companies
Same sector (Professional Services), similar size
Data detected 2026-07-20 · Methodology · Suggest a correction